Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Ultragenyx Pharmaceutical
RARE
$2.61B
| $12.8M | ﹤0.01% |
276,683
-281,133
| -50% | -$13M |
|
2327
CALL
Chord Energy
CHRD
$7.51B
| $12.8M | ﹤0.01% |
82,900
-35,600
| -30% | -$5.16M |
|
2328
Jazz Pharmaceuticals
JAZZ
$15.9B
| $12.7M | ﹤0.01% |
102,800
-169,769
| -62% | -$22.8M |
|
2329
PUT
Noble Corp
NE
$7.2B
| $12.7M | ﹤0.01% |
307,800
+32,100
| +12% | +$1.24M |
|
2330
Lincoln Electric
LECO
$15.6B
| $12.7M | ﹤0.01% |
63,900
+63,278
| +10,173% | +$11M |
|
2331
Ollie's Bargain Outlet
OLLI
$4.62B
| $12.7M | ﹤0.01% |
218,964
+106,873
| +95% | +$6.58M |
|
2332
Yum China
YUMC
$16.3B
| $12.7M | ﹤0.01% |
224,184
+224,047
| +163,538% | +$13.5M |
|
|
ISEE
2333
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $12.6M | ﹤0.01% |
321,200
+89,000
| +38% | +$3.14M |
|
|
WIRE
2334
CALL
DELISTED
Encore Wire Corp
WIRE
| $12.6M | ﹤0.01% |
67,900
+5,500
| +9% | +$931K |
|
|
ALTR
2335
DELISTED
Altair Engineering Inc
ALTR
| $12.6M | ﹤0.01% |
166,402
-243,731
| -59% | -$17.4M |
|
2336
Banco Bradesco
BBD
$34.2B
| $12.6M | ﹤0.01% |
3,641,482
+3,528,426
| +3,121% | +$10.9M |
|
2337
Direxion Daily Financial Bull 3x ETF
FAS
$2.49B
| $12.6M | ﹤0.01% |
198,152
-35,993
| -15% | -$2.12M |
|
2338
Xerox
XRX
$407M
| $12.5M | ﹤0.01% |
842,694
-57,148
| -6% | -$837K |
|
|
HCP
2339
PUT
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $12.5M | ﹤0.01% |
479,000
+229,300
| +92% | +$6.72M |
|
2340
S&P Global
SPGI
$123B
| $12.5M | ﹤0.01% |
31,258
-653,771
| -95% | -$239M |
|
2341
DXC Technology
DXC
$1.72B
| $12.5M | ﹤0.01% |
468,833
+466,652
| +21,396% | +$11.6M |
|
2342
New York Times
NYT
$10.4B
| $12.5M | ﹤0.01% |
317,593
+185,296
| +140% | +$7.05M |
|
2343
Pediatrix Medical
MD
$2.16B
| $12.5M | ﹤0.01% |
878,852
+108,240
| +14% | +$1.52M |
|
2344
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $12.5M | ﹤0.01% |
253,562
+115,128
| +83% | +$5.67M |
|
2345
MP Materials
MP
$10.5B
| $12.5M | ﹤0.01% |
544,878
+241,272
| +79% | +$5.53M |
|
2346
Vanguard Morningstar Growth ETF
VUG
$230B
| $12.4M | ﹤0.01% |
263,946
+120,006
| +83% | +$5.2M |
|
2347
CALL
Equifax
EFX
$21.2B
| $12.4M | ﹤0.01% |
52,800
-9,500
| -15% | -$2M |
|
2348
Korn Ferry
KFY
$4.32B
| $12.4M | ﹤0.01% |
250,772
+198,856
| +383% | +$9.78M |
|
2349
PUT
Academy Sports + Outdoors
ASO
$2.98B
| $12.4M | ﹤0.01% |
229,800
-168,700
| -42% | -$9.69M |
|
|
ESTE
2350
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $12.4M | ﹤0.01% |
868,928
-95,412
| -10% | -$1.27M |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.